Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: In vitro and in vivo studies

Journal of Colloid and Interface Science

Volumn 445, Issue , 2015, Pages 219-230

  Jyoti, Kiran ^a   Kaur, Karanvir ^a   Pandey, Ravi Shankar ^b   Jain, Upendra Kumar ^a   Chandra, Ramesh ^c   Madan, Jitender ^a  

^a Chandigarh College of Pharmacy   (India)

^b GURU GHASIDAS UNIVERSITY   (India)

^c UNIVERSITY OF DELHI   (India)

Author keywords

9 Bromo noscapine; Apoptosis; Cellular uptake; Cytotoxicity; Inhalable nanoparticles; Pharmacokinetics

Indexed keywords

BIOLOGICAL ORGANS; CELL DEATH; CYTOTOXICITY; DISEASES; MOLECULAR BIOLOGY; NANOPARTICLES; PARTICLE SIZE; PHARMACOKINETICS; TARGETED DRUG DELIVERY;

9-BROMO-NOSCAPINE; CELLULAR UPTAKE; DISTRIBUTION ANALYSIS; ENHANCED DISSOLUTIONS; INHALABLE; NON SMALL CELL LUNG CANCER; THERAPEUTIC EFFICACY; TUBULIN POLYMERIZATION;

CONTROLLED DRUG DELIVERY;

9 BROMO NOSCAPINE; BREFELDIN A; CASPASE 3; CYTOTOXIC AGENT; EXCIPIENT; FILIPIN; INHALABLE NANOSTRUCTURED LIPID PARTICLE; NANOCARRIER; NOSCAPINE; TUBULIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DRUG CARRIER; LIPID; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG RELEASE; DRUG SAFETY; DRUG SOLUBILITY; DRUG UPTAKE; ELIMINATION RATE CONSTANT; ENDOCYTOSIS; ENDOSOME; GOLGI COMPLEX; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LIPOPHILICITY; LUNG CANCER CELL LINE; MALE; MEAN RESIDENCE TIME; MICROTUBULE ASSEMBLY; MOUSE; NANOEMULSION; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PINOCYTOSIS; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; VOLUME OF DISTRIBUTION; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; ANIMAL; CARCINOMA, NON-SMALL-CELL LUNG; CHEMISTRY; DRUG EFFECTS; HALOGENATION; INHALATIONAL DRUG ADMINISTRATION; LUNG; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADMINISTRATION, INHALATION; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DRUG CARRIERS; HALOGENATION; HUMANS; LIPIDS; LUNG; LUNG NEOPLASMS; MALE; MICE; NANOPARTICLES; NOSCAPINE; PARTICLE SIZE; TUBULIN;

EID: 84921515442     PISSN: 00219797     EISSN: 10957103     Source Type: Journal    
DOI: 10.1016/j.jcis.2014.12.092     Document Type: Article

References (63)

1. Aneja R., Zhou J., Zhou B., Chandra R., Joshi H.C. Mol. Cancer Ther. 2006, 5:2366-2377.
2. Verma A.K., Bansal S., Singh J., Tiwari R.K., Kasi Sankar V., Tandon V., Chandra R. Bioorg. Med. Chem. 2006, 14:6733-6736.
3. Jackson T., Chougule M.B., Ichite N., Patlolla R.R., Singh M. Cancer Chemother. Pharmacol. 2008, 63:117-126.
4. Chougule M.B., Patel A., Sachdeva P., Jackson T., Singh M. PLoS One 2011, 6:e27394.
5. Chougule M., Patel A.R., Sachdeva P., Jackson T., Singh M. Lung Cancer 2011, 71:271-282.
6. Madan J., Pandey R.S., Jain U.K., Katare O.P., Aneja R., Katyal A. Colloids Surf. B: Biointerface 2013, 107:235-244.
7. Karna P., Sharp S.M., Yates C., Prakash S., Aneja R. Mol. Cancer 2009, 8:93.
8. Zhou J., Gupta K., Aggarwal S., Aneja R., Chandra R., Panda D., Joshi H.C. Mol. Pharmacol. 2003, 63:799-807.
9. Karna P., Rida P.C., Turaga R.C., Gao J., Gupta M., Fritz A., Werner E., Yates C., Zhou J., Aneja R. Carcinogenesis 2012, 33:1769-1781.
10. Madan J., Baruah B., Nagaraju M., Abdalla M.O., Yates C., Turner T., Rangari V., Hamelberg D., Aneja R. Mol. Pharm. 2012, 9:1470-1480.
11. Rubin B.K., Williams R.W. Adv. Drug Delivery Rev. 2014, 75C:141-148.
12. Garbuzenko O.B., Mainelis G., Taratula O., Minko T. Cancer Biol. Med. 2014, 11:44-55.
13. Mainelis G., Seshadri S., Garbuzenko O.B., Han T., Wang Z., Minko T. J. Aerosol Med. Pulm. Drug Delivery 2013, 26:345-354.
14. Willis L., Hayes D., Mansour H.M. Lung 2012, 190:251-262.
15. Zarogoulidis P., Darwiche K., Hohenforst-Schmidt W., Huang H., Li Q., Freitag L., Zarogoulidis K. Future Oncol. 2013, 9:1171-1194.
16. Meenach S.A., Anderson K.W., Zach Hilt J., McGarry R.C., Mansour H.M. Eur. J. Pharm. Sci. 2013, 49:699-711.
17. Tian Y., Klegerman M.E., Hickey A.J. PDA J. Pharm. Sci. Technol. 2004, 58:266-275.
18. Bhattarai S.R., Kim S.Y., Jang K.Y., Yi H.K., Lee Y.H., Bhattarai N., Nam S.Y., Lee D.Y., Kim H.Y., Hwang P.H. Gene Ther. 2007, 14:476-483.
19. Yang W., Peters J.I., Williams R.O. Int. J. Pharm. 2008, 356:239-247.
20. Paranjpe M., Muller-Goymann C.C. Int. J. Mol. Sci. 2014, 15:5852-5873.
21. Saini J., Bansal V., Chandra A., Madan J., Jain U.K., Chandra R., Jain S.M. Colloids Surf. B: Biointerface 2014, 118:101-110.
22. Madan J., Pandey R.S., Jain V., Katare O.P., Chandra R., Katyal A. Nanomedicine 2013, 9:492-503.
23. Ozsoy Y., Gungor S. Expert Opin. Drug Delivery 2011, 8:1439-1453.
24. Patlolla R.R., Chougule M., Patel A.R., Jackson T., Tata P.N., Singh M. J. Control. Release 2010, 144:233-241.
25. Wei C.C., Ge Z.Q. Drug Dev. Ind. Pharm. 2012, 38:1084-1089.
26. Zimmermann E., Muller R.H. Eur. J. Pharm. Biopharm. 2001, 52:203-210.
27. Barman R.K., Iwao Y., Funakoshi Y., Ranneh A.H., Noguchi S., Wahed M.I., Itai S. Chem. Pharm. Bull. (Tokyo) 2014, 62:399-406.
28. Azarmi S., Lobenberg R., Roa W.H., Tai S., Finlay W.H. Drug Dev. Ind. Pharm. 2008, 34:943-947.
29. Roa W.H., Azarmi S., Al-Hallak M.H., Finlay W.H., Magliocco A.M., Lobenberg R. J. Control. Release 2011, 150:49-55.
30. Zhang P., Gao W.Y., Turner S., Ducatman B.S. Mol. Cancer 2003, 2:1-9.
31. Mao S.R., Wang Y.Z., Ji H.Y., Bi D.Z. Yao Xue Xue Bao 2003, 38:624-626.
32. Vogel R., Meredith P., Harvey M.D., Rubinsztein-Dunlop H. Spectrochim. Acta Part A 2004, 60:245-249.
33. Guo H., Qian H., Sun S., Sun D., Yin H., Cai X., Liu Z., Wu J., Jiang T., Liu X. Chem. Central J. 2011, 5:1-10.
34. Gao Z., Westenberger B. AAPS PharmSciTech. 2012, 13:944-948.
35. Yamasaki K., Kwok P.C., Fukushige K., Prud'homme R.K., Chan H.K. Int. J. Pharm. 2011, 420:34-42.
36. Vankateswarlu V., Manjunath K. J. Control. Release 2004, 95:627-638.
37. Mosmann T. J. Immunol. Methods 1983, 65:55-63.
38. Yallapu M.M., Jaggi M., Chauhan S.C. Colloids Surf. B: Biointerface 2010, 79:113-125.
39. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Anal. Biochem. 1985, 150:76-85.
40. Sharma R., Saxena D., Dwivedi A.K., Misra A. Pharm. Res. 2001, 18:1405-1410.
41. Hu F.Q., Jiang S.P., Du Y.Z., Yuan H., Ye Y.Q., Zeng S. Colloids Surf. B Biointerface 2005, 45:167-173.
42. Sosnowski T.R. J. Thorac. Dis. 2011, 3:153-155.
43. Roy I., Vij N. Nanomedicine 2010, 6:237-244.
44. Gill S., Lobenberg R., Ku T., Azarmi S., Roa W.H., Prenner E.J. J. Biomed. Nanotechnol. 2007, 3:107-119.
45. Oberdorster G., Oberdorster E., Oberdorster J. Environ. Health Perspect. 2005, 113:823-839.
46. Muhlfeld C., Rothen-Rutishauser B., Blank F., Vanhecke D., Ochs M., Gehr P. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L817-L829.
47. Al-Hallak M.H., Azarmi S., Sun C., Lai P., Prenner E.J., Roa W.H., Lobenberg R. AAPS J. 2010, 12:294-299.
48. He C., Hu Y., Yin L., Tang C., Yin C. Biomaterials 2010, 31:3657-3666.
49. Yamamoto A., Tanaka H., Okumura S., Shinsako K., Ito M., Yamashita M., Okada N., Fujita T., Muranishi S. Biol. Pharm. Bull. 2001, 24:385-389.
50. Groneberg D.A., Witt C., Wagner U., Chung K.F., Fischer A. Respir. Med. 2003, 97:382-387.
51. Yang Y., Corona A., Henson M.A. J. Colloid Interface Sci. 2012, 374:297-307.
52. Gallagher J.E., George G., Brody A.R. Am. Rev. Respir. Dis. 1987, 135:1345-1352.
53. Bartneck M., Keul H.A., Singh S., Czaja K., Bornemann J., Bockstaller M., Moeller M., Zwadlo-Klarwasser G., Groll J. ACS Nano 2010, 4:3073-3086.
54. Jenning V., Thunemann A.F., Gohla S.H. Int. J. Pharm. 2000, 199:167-177.
55. Zhang Q., Zhang Y., Chen W., Zhang B., Wang S. Exp. Ther. Med. 2013, 6:1443-1448.
56. Foster K.A., Oster C.G., Mayer M.M., Avery M.L., Audus K.L. Exp. Cell Res. 1998, 243:359-366.
57. Azarmi S., Roa W.H., Lobenberg R. Adv. Drug Delivery Rev. 2008, 60:863-875.
58. Ding J.C., Hu F.Q., Yuan H. Acta Pharm. Sinica 2004, 39:876-880.
59. Liu J., Shapiro J.I. Biol. Res. Nurs. 2003, 5:117-128.
60. Rivolta I., Panariti A., Lettiero B., Sesana S., Gasco P., Gasco M.R., Masserini M., Miserocchi G. J. Physiol. Pharmacol. 2011, 62:45-53.
61. Short M.D., Singh C.A., Few J.D., Studdy P.R., Heaf P.J., Spiro S.G. Chest 1981, 80(6 suppl):918-921.
62. Niven R.W. Crit. Rev. Ther. Drug Carrier Syst. 1995, 12:151-231.
63. Videira M.A., Gano L., Santos C., Neves M., Almeida A.J. J. Microencapsul. 2006, 23:855-862.